Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19

NCT04374617 is registered in ClinicalTrials.gov with Hospital Universitari Vall d'Hebron Research Institute as lead sponsor.

NCT NCT04374617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04374617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19
Lead sponsor
Hospital Universitari Vall d'Hebron Research Institute
Phase
Observational
Overall status
Completed
Start date
April 1, 2020
Completion date
May 1, 2020
Enrollment
230 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, critical illness, pulmonary embolism, pulmonary embolism and thrombosis, sars-cov infection, sars-cov2, venous thromboembolism, venous thromboses, venous thromboses, deep, venous thrombosis pulmonary